Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction

Industry Reports
Typography

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros.

Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.Ferring is Apricus’ existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners. Apricus will retain its Vitaros rights in the U.S.

"Urology is a key therapeutic area for Ferring," said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. “This agreement strengthens our existing portfolio and reinforces Ferring’s commitment to improving the quality of life of patients with a broad range of urological conditions.”

About Ferring Pharmaceuticals
Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com. 

*Vitaros® is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.  Such trademark is registered in certain countries throughout the world and pending registration in the United States.

For more information:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Sign up via our free email subscription service to receive notifications when new information is available.
captcha 

Market Movers

Rogers Corporation

NYQ : ROG - 16 Oct, 4:02pm
139.53
+2.83 (+2.07%) After Hours:
Open 137.60 Mktcap 2.54B
High 139.74 52wk Hight 139.74
Low 137.05 52wk Low 51.98
Vol 86121 Avg Vol 120528
Eps 5.55 P/e 33.70
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 16 Oct, 4:04pm
6.52
-0.01 (-0.11%) After Hours:
Open 6.51 Mktcap 20.57B
High 6.53 52wk Hight 6.99
Low 6.47 52wk Low 4.36
Vol 3.84M Avg Vol 5.41M
Eps 0.49 P/e 11.99
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 16 Oct, 4:00pm
63.34
-0.05 (-0.08%) After Hours:
Open 63.49 Mktcap 172.75B
High 63.73 52wk Hight 66.80
Low 63.26 52wk Low 58.29
Vol 7.45M Avg Vol 7.72M
Eps 3.87 P/e 34.24
Currency: USD

Johnson & Johnson

NYQ : JNJ - 16 Oct, 4:00pm
136.12
-0.31 (-0.23%) After Hours:
Open 136.45 Mktcap 365.35B
High 137.26 52wk Hight 137.52
Low 135.54 52wk Low 109.32
Vol 5.12M Avg Vol 5.26M
Eps 7.18 P/e 22.88
Currency: USD

Pfizer, Inc.

NYQ : PFE - 16 Oct, 4:00pm
35.98
-0.36 (-0.99%) After Hours:
Open 36.35 Mktcap 59.45B
High 36.48 52wk Hight 36.60
Low 35.88 52wk Low 29.83
Vol 13.58M Avg Vol 17.16M
Eps 2.56 P/e 26.26
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 16 Oct, 3:37pm
13.81
+0.06 (+0.44%) After Hours:
Open Mktcap
High 52wk Hight 16.29
Low 52wk Low 13.12
Vol 0 Avg Vol 3888
Eps P/e
Currency: USD